Enter your current warfarin (Coumadin) maintenance dose, therapeutic INR range, and current INR to get a nomogram-style weekly dose-adjustment suggestion. Warfarin adjustments should be individualized by a clinician.

Coumadin Adjustment Calculator

Estimates a weekly percent adjustment based on a commonly used outpatient maintenance-style nomogram. Clinic protocols vary.

Safety notice: Seek emergency care now for signs of bleeding or neurologic symptoms (e.g., vomiting/coughing blood, black/tarry stools, severe headache, weakness, fainting), or after any fall/head injury. For high INRs, do not change or “hold” warfarin on your own—contact your anticoagulation clinic/clinician urgently; reversal decisions (vitamin K/blood products) must be clinician-directed. This calculator is informational and may not match your clinic’s protocol.

Coumadin Adjustment Formula

For maintenance therapy, warfarin (Coumadin) dose changes are typically made as percentage adjustments to the total weekly dose using a dosing nomogram and clinical judgment (not by directly scaling the dose to the INR). This is one example approach; your anticoagulation clinic’s protocol may differ. For clinician-directed guidance, consult your institution’s anticoagulation service protocol and major professional guidelines (for example, CHEST/ACCP resources on warfarin management).

  • Adjusted weekly dose (mg/week) = Current weekly dose × (1 + Δ/100),
    where Δ is a percent change chosen from a nomogram (often using the midpoint of a recommended range). Example ranges for goal INR 2.0–3.0 (general outpatient maintenance-style guidance; protocols vary):
    • INR <1.5: many protocols consider increasing ~10–20%
    • 1.5–1.7: many protocols consider increasing ~5–15%
    • 1.8–1.9: many protocols consider increasing ~5–10%
    • 2.0–3.0: often no change
    • 3.1–3.2: often no change (some clinics may consider a small decrease)
    • 3.3–4.4: some clinics may consider decreasing ~5–10%
    • ≥4.5: requires urgent clinician-directed reassessment; do not self-adjust, and seek emergency care for any bleeding or head injury.

What is a Coumadin Adjustment?

A Coumadin adjustment refers to the process of altering the dosage of the medication Coumadin (also known as warfarin), which is an anticoagulant used to help prevent and treat blood clots. This adjustment is typically made based on a patient’s blood test results, specifically the International Normalized Ratio (INR), a standardized number derived from the prothrombin time (PT) test that reflects how quickly blood clots. If the INR is too high, bleeding risk increases; if it’s too low, clotting risk increases. Therefore, the dose may need to be increased or decreased to maintain a safe and effective therapeutic INR range.

How to Calculate Coumadin Adjustment?

The following steps outline how to calculate a Coumadin (warfarin) maintenance dose adjustment.


  1. Determine the patient’s current maintenance dose of warfarin (preferably as a total weekly dose in mg/week).
  2. Determine the therapeutic INR range (for example, 2.0–3.0 or 2.5–3.5, depending on indication).
  3. Measure the current INR.
  4. Use a dosing nomogram (and clinical context, including bleeding/clotting symptoms, interacting medications, diet changes, missed doses, etc.) to choose an appropriate percent change Δ to the weekly dose.
  5. Calculate the new weekly dose: New weekly dose = Current weekly dose × (1 + Δ/100).
  6. Convert the new weekly dose into a practical clinician-prescribed schedule (often using alternating daily doses) and recheck INR at an appropriate interval per clinic protocol.
  7. After inserting the variables and calculating the result, check your answer with the calculator above.

Example Problem : 

Use the following variables as an example problem to test your knowledge.

Current maintenance dose = 5 mg/day (35 mg/week)

Therapeutic INR range = 2.0–3.0

Current INR = 3.2. Recommendation (goal 2.0–3.0): this is often managed with no change (some clinics may make a small 5–10% weekly decrease); a no-change weekly dose remains about 35 mg/week (daily equivalent 5 mg/day), with INR recheck per clinic protocol.